Evidence 1
Activity
Activity
5% Hemolysis
Toxicity
160 µg/mL
Hemolytic
Cytotoxic
5% Hemolysis | 160 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates. | Eur J Med Chem | 2014